Agha Sohail, Ruiz-Gaona Laura Alejandra, Friedman Jed, Cheikh Nejma, Gorgens Marelize
Behavior Design Lab, Stanford University, Stanford, CA, USA.
World Bank Group, Washington, DC, USA.
Digit Health. 2022 Nov 30;8:20552076221142666. doi: 10.1177/20552076221142666. eCollection 2022 Jan-Dec.
Patent proprietary medicine vendors (PPMVs) are the first point of care for low-income Nigerian households. They are likely to have an important role in a digital care pathway established for low-income Nigerian women and children. Yet, little is known about what drives the adoption of digital platforms by PPMVs.
This study explores factors associated with the adoption of a digital service, NaijaCare, created to enable PPMVs to increase the range and quality of products and services they offer. A structured, quantitative, face-to-face survey was conducted among 248 PPMVs in Lagos in February and March 2020. Multivariate analysis was conducted to identify factors associated with the adoption of NaijaCare.
Women comprise the majority (67%) of medicine vendors in Lagos. Most medicine vendors (64%) had gotten health training on the job. About a quarter (27%) of medicine vendors reported seeking business advice on the internet. Medicine vendors who had obtained on-the-job training had a 12.31 times higher odds ratio ( < 0.01) of adopting the digital service. Medicine vendors who sought business advice on the internet had a 6.48 times higher odds ratio ( < 0.001) of adopting NaijaCare.
The study findings suggest that PPMVs' use of the digital service was driven by their desire to increase business profits. Digital care pathways targeting low-income households should be aligned with the business interests of informal providers.
专利成药供应商是尼日利亚低收入家庭的首要医疗服务提供者。他们在为尼日利亚低收入妇女和儿童建立的数字医疗路径中可能发挥重要作用。然而,对于促使专利成药供应商采用数字平台的因素却知之甚少。
本研究探讨与采用数字服务NaijaCare相关的因素,该服务旨在使专利成药供应商能够增加其提供的产品和服务的范围及质量。2020年2月和3月,在拉各斯对248名专利成药供应商进行了结构化、定量的面对面调查。进行多变量分析以确定与采用NaijaCare相关的因素。
在拉各斯,女性占药品供应商的大多数(67%)。大多数药品供应商(64%)在工作中接受过健康培训。约四分之一(27%)的药品供应商报告称在互联网上寻求过商业建议。接受过在职培训的药品供应商采用该数字服务的优势比高12.31倍(<0.01)。在互联网上寻求商业建议的药品供应商采用NaijaCare的优势比高6.48倍(<0.001)。
研究结果表明,专利成药供应商对数字服务的使用是由其增加商业利润的愿望驱动的。针对低收入家庭的数字医疗路径应与非正规医疗服务提供者的商业利益保持一致。